| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |